vs

Side-by-side financial comparison of F5, Inc. (FFIV) and STEPAN CO (SCL). Click either name above to swap in a different company.

F5, Inc. is the larger business by last-quarter revenue ($811.7M vs $604.5M, roughly 1.3× STEPAN CO). F5, Inc. runs the higher net margin — 18.2% vs 3.3%, a 15.0% gap on every dollar of revenue. On growth, F5, Inc. posted the faster year-over-year revenue change (11.0% vs 1.9%). Over the past eight quarters, F5, Inc.'s revenue compounded faster (8.0% CAGR vs 4.2%).

F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

FFIV vs SCL — Head-to-Head

Bigger by revenue
FFIV
FFIV
1.3× larger
FFIV
$811.7M
$604.5M
SCL
Growing faster (revenue YoY)
FFIV
FFIV
+9.1% gap
FFIV
11.0%
1.9%
SCL
Higher net margin
FFIV
FFIV
15.0% more per $
FFIV
18.2%
3.3%
SCL
Faster 2-yr revenue CAGR
FFIV
FFIV
Annualised
FFIV
8.0%
4.2%
SCL

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
FFIV
FFIV
SCL
SCL
Revenue
$811.7M
$604.5M
Net Profit
$148.0M
$19.7M
Gross Margin
81.4%
10.7%
Operating Margin
22.1%
4.7%
Net Margin
18.2%
3.3%
Revenue YoY
11.0%
1.9%
Net Profit YoY
1.5%
EPS (diluted)
$2.58
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFIV
FFIV
SCL
SCL
Q1 26
$811.7M
$604.5M
Q4 25
$822.5M
$553.9M
Q3 25
$810.1M
$590.3M
Q2 25
$780.4M
$594.7M
Q1 25
$731.1M
$593.3M
Q4 24
$766.5M
$525.6M
Q3 24
$746.7M
$546.8M
Q2 24
$695.5M
$556.4M
Net Profit
FFIV
FFIV
SCL
SCL
Q1 26
$148.0M
$19.7M
Q4 25
$180.1M
$5.0M
Q3 25
$190.5M
$10.8M
Q2 25
$189.9M
$11.3M
Q1 25
$145.5M
$19.7M
Q4 24
$166.4M
$3.4M
Q3 24
$165.3M
$23.6M
Q2 24
$144.1M
$9.5M
Gross Margin
FFIV
FFIV
SCL
SCL
Q1 26
81.4%
10.7%
Q4 25
81.5%
9.3%
Q3 25
82.2%
12.0%
Q2 25
81.0%
12.1%
Q1 25
80.7%
12.7%
Q4 24
81.7%
10.8%
Q3 24
80.8%
13.8%
Q2 24
80.4%
12.5%
Operating Margin
FFIV
FFIV
SCL
SCL
Q1 26
22.1%
4.7%
Q4 25
26.0%
1.9%
Q3 25
25.4%
3.7%
Q2 25
25.2%
3.0%
Q1 25
21.7%
4.8%
Q4 24
26.8%
1.5%
Q3 24
25.6%
4.4%
Q2 24
23.4%
3.4%
Net Margin
FFIV
FFIV
SCL
SCL
Q1 26
18.2%
3.3%
Q4 25
21.9%
0.9%
Q3 25
23.5%
1.8%
Q2 25
24.3%
1.9%
Q1 25
19.9%
3.3%
Q4 24
21.7%
0.6%
Q3 24
22.1%
4.3%
Q2 24
20.7%
1.7%
EPS (diluted)
FFIV
FFIV
SCL
SCL
Q1 26
$2.58
$0.86
Q4 25
$3.10
$0.22
Q3 25
$3.25
$0.47
Q2 25
$3.25
$0.50
Q1 25
$2.48
$0.86
Q4 24
$2.82
$0.14
Q3 24
$2.79
$1.03
Q2 24
$2.44
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFIV
FFIV
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$328.4M
Stockholders' EquityBook value
$3.6B
$1.2B
Total Assets
$6.5B
$2.3B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFIV
FFIV
SCL
SCL
Q1 26
$1.4B
Q4 25
$1.2B
$132.7M
Q3 25
$1.3B
$118.5M
Q2 25
$1.4B
$88.9M
Q1 25
$1.3B
$107.5M
Q4 24
$1.2B
$99.7M
Q3 24
$1.1B
$147.3M
Q2 24
$935.6M
$124.7M
Total Debt
FFIV
FFIV
SCL
SCL
Q1 26
$328.4M
Q4 25
$626.7M
Q3 25
$655.5M
Q2 25
$658.0M
Q1 25
$659.3M
Q4 24
$625.4M
Q3 24
$688.5M
Q2 24
$657.1M
Stockholders' Equity
FFIV
FFIV
SCL
SCL
Q1 26
$3.6B
$1.2B
Q4 25
$3.5B
$1.2B
Q3 25
$3.6B
$1.2B
Q2 25
$3.5B
$1.2B
Q1 25
$3.3B
$1.2B
Q4 24
$3.2B
$1.2B
Q3 24
$3.1B
$1.2B
Q2 24
$3.0B
$1.2B
Total Assets
FFIV
FFIV
SCL
SCL
Q1 26
$6.5B
$2.3B
Q4 25
$6.3B
$2.4B
Q3 25
$6.3B
$2.4B
Q2 25
$6.1B
$2.4B
Q1 25
$5.9B
$2.4B
Q4 24
$5.9B
$2.3B
Q3 24
$5.6B
$2.4B
Q2 24
$5.4B
$2.3B
Debt / Equity
FFIV
FFIV
SCL
SCL
Q1 26
0.28×
Q4 25
0.50×
Q3 25
0.53×
Q2 25
0.53×
Q1 25
0.55×
Q4 24
0.53×
Q3 24
0.56×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFIV
FFIV
SCL
SCL
Operating Cash FlowLast quarter
$525.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFIV
FFIV
SCL
SCL
Q1 26
$525.1M
Q4 25
$159.2M
$60.0M
Q3 25
$208.1M
$69.8M
Q2 25
$282.2M
$11.2M
Q1 25
$256.6M
$6.9M
Q4 24
$202.8M
$68.3M
Q3 24
$246.5M
$22.7M
Q2 24
$159.0M
$29.5M
Free Cash Flow
FFIV
FFIV
SCL
SCL
Q1 26
Q4 25
$149.5M
$25.4M
Q3 25
$191.9M
$40.2M
Q2 25
$273.7M
$-14.4M
Q1 25
$246.1M
$-25.8M
Q4 24
$194.7M
$32.1M
Q3 24
$240.4M
$-4.0M
Q2 24
$153.1M
$-208.0K
FCF Margin
FFIV
FFIV
SCL
SCL
Q1 26
Q4 25
18.2%
4.6%
Q3 25
23.7%
6.8%
Q2 25
35.1%
-2.4%
Q1 25
33.7%
-4.3%
Q4 24
25.4%
6.1%
Q3 24
32.2%
-0.7%
Q2 24
22.0%
-0.0%
Capex Intensity
FFIV
FFIV
SCL
SCL
Q1 26
Q4 25
1.2%
6.3%
Q3 25
2.0%
5.0%
Q2 25
1.1%
4.3%
Q1 25
1.4%
5.5%
Q4 24
1.1%
6.9%
Q3 24
0.8%
4.9%
Q2 24
0.8%
5.3%
Cash Conversion
FFIV
FFIV
SCL
SCL
Q1 26
3.55×
Q4 25
0.88×
11.99×
Q3 25
1.09×
6.44×
Q2 25
1.49×
0.99×
Q1 25
1.76×
0.35×
Q4 24
1.22×
20.38×
Q3 24
1.49×
0.96×
Q2 24
1.10×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FFIV
FFIV

Segment breakdown not available.

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons